Aim for 25 to 35 grams of fiber daily from whole grains, vegetables, fruit, and legumes
Tirzepatide is a 39-amino-acid synthetic peptide that engages two metabolic receptors simultaneously the GIP receptor and the GLP-1 receptor making it the first dual-incretin-receptor agonist to enter widespread clinical research
Try to stick to low-fat foods, especially for two or three days after an injection
Slowing Gastric Emptying: This medication delays the speed at which food leaves the stomach, creating a feeling of fullness that lasts longer
The Cleveland Clinic analysis counted a discontinuation only after a gap of more than 90 days between exhaustion of supply and the next dispense, and states directly that patients who switched between injectable semaglutide, tirzepatide, or other anti-obesity agents with a gap under 90 days were not counted as having discontinued
Compounded tirzepatide injection (dual GIP/GLP-1 receptor agonist) is $289/mo month-to-month (or $249/mo on the 6-month plan) and often produces faster, more robust weight loss in patients who experience plateaus with semaglutide alone